Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Assets Average (2016 - 2026)

Pharma-Bio Serv's Assets Average history spans 14 years, with the latest figure at $13.6 million for Q1 2026.

  • For Q1 2026, Assets Average fell 15.97% year-over-year to $13.6 million; the TTM value through Jan 2026 reached $13.6 million, down 15.97%, while the annual FY2025 figure was $15.0 million, 17.27% down from the prior year.
  • Assets Average reached $13.6 million in Q1 2026 per PBSV's latest filing, roughly flat from $13.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $23.0 million in Q1 2022 to a low of $13.6 million in Q1 2026.
  • Average Assets Average over 5 years is $18.3 million, with a median of $19.6 million recorded in 2024.
  • Peak YoY movement for Assets Average: dropped 28.33% in 2022, then rose 0.67% in 2023.
  • A 5-year view of Assets Average shows it stood at $20.5 million in 2022, then fell by 1.91% to $20.1 million in 2023, then dropped by 18.88% to $16.3 million in 2024, then dropped by 16.47% to $13.6 million in 2025, then fell by 0.14% to $13.6 million in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Assets Average are $13.6 million (Q1 2026), $13.6 million (Q4 2025), and $13.7 million (Q3 2025).